Literature DB >> 7852037

Tumor blood flow measured using dynamic computed tomography.

H Hattori1, T Miyoshi, J Okada, K Yoshikawa, N Arimizu, N Hattori.   

Abstract

RATIONALE AND
OBJECTIVES: A method for measuring the tumor blood flow (TBF) by means of dynamic computed tomography (DCT) was devised and investigated.
METHODS: Twenty-seven patients with superficial tumors underwent measurement of TBF by the new DCT method. For all of the 27 patients, the thermal clearance method was employed to measure the relative tumor blood flow (RTBF). For 16 patients, TBF was measured by oxygen-15-gas positron-emission tomography (PET). The TBF values measured by DCT were compared with the RTBF by the thermal clearance method and the TBF by PET.
RESULTS: The results demonstrated a linear relationship.
CONCLUSIONS: The newly devised DCT method yields reliable data in measuring TBF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7852037     DOI: 10.1097/00004424-199410000-00002

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  4 in total

1.  Functional CT imaging in oncology.

Authors:  K A Miles
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

2.  Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET.

Authors:  K A Miles; R E Williams; D Yu; M R Griffiths
Journal:  Int J Mol Imaging       Date:  2011-04-26

Review 3.  New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know.

Authors:  Frederico F Souza; Andrew Smith; Cyrillo Araujo; Jyothi Jagannathan; Ciaran Johnston; Kevin O'Regan; Atul Shinagare; Nikhil Ramaiya
Journal:  Cancer Imaging       Date:  2014-07-23       Impact factor: 3.909

4.  Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography.

Authors:  K A Miles; T-Y Lee; V Goh; E Klotz; C Cuenod; S Bisdas; A M Groves; M P Hayball; R Alonzi; T Brunner
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.